Literature DB >> 27063271

Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.

Andrea Marengo1, Ramy Ibrahim Kamal Jouness1, Elisabetta Bugianesi2.   

Abstract

Liver-related mortality is the third cause of death in patients with nonalcoholic fatty liver disease, but the long-term prognosis basically depends on the presence and severity of liver damage. Thus, life expectancy in patients with simple steatosis is not different from the general population, but liver-related mortality is significantly higher in patients with nonalcoholic steatohepatitis (NASH), particularly in those with advanced fibrosis. Progression of liver disease is observed in up to one-third of patients with NASH. The long-term hepatic prognosis mostly depends on the histologic stage at initial liver biopsy, but multiple risk factors may concur.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Hepatocellular carcinoma; Obesity; Steatohepatitis; Type 2 diabetes

Mesh:

Year:  2015        PMID: 27063271     DOI: 10.1016/j.cld.2015.10.010

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  44 in total

1.  Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.

Authors:  Mohammad Nasser Kabbany; Praveen Kumar Conjeevaram Selvakumar; Kymberly Watt; Rocio Lopez; Zade Akras; Nizar Zein; William Carey; Naim Alkhouri
Journal:  Am J Gastroenterol       Date:  2017-02-14       Impact factor: 10.864

2.  Liver fibrosis scores predict liver disease mortality in the United States population.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Hepatology       Date:  2017-05-16       Impact factor: 17.425

Review 3.  Gastric Bypass and Influence on Improvement of NAFLD.

Authors:  Vamsi Alli; Ann M Rogers
Journal:  Curr Gastroenterol Rep       Date:  2017-06

4.  Bariatric Surgery and Liver Transplantation.

Authors:  Duminda Suraweera; Elena G Saab; Gina Choi; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-03

5.  Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.

Authors:  Fanhong Zeng; Yue Zhang; Xu Han; Min Zeng; Yi Gao; Jun Weng
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

6.  ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model.

Authors:  Susanne Schuster-Gaul; Lukas Jonathan Geisler; Matthew D McGeough; Casey D Johnson; Anna Zagorska; Li Li; Alexander Wree; Vivian Barry; Igor Mikaelian; Lily J Jih; Bettina G Papouchado; Grant Budas; Hal M Hoffman; Ariel E Feldstein
Journal:  JCI Insight       Date:  2020-01-30

7.  Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis.

Authors:  Sayuri Takada; Tsutomu Matsubara; Hideki Fujii; Misako Sato-Matsubara; Atsuko Daikoku; Naoshi Odagiri; Yuga Amano-Teranishi; Norifumi Kawada; Kazuo Ikeda
Journal:  Lab Invest       Date:  2020-12-10       Impact factor: 5.662

Review 8.  Stable isotope-based flux studies in nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen Previs; Takhar Kasumov
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

9.  Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.

Authors:  Graham F Brady; Raymond Kwan; Peter J Ulintz; Phirum Nguyen; Shirin Bassirian; Venkatesha Basrur; Alexey I Nesvizhskii; Rohit Loomba; M Bishr Omary
Journal:  Hepatology       Date:  2018-03-24       Impact factor: 17.425

10.  Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass.

Authors:  Joshua S Winder; Brandon S Dudeck; Sarayna Schock; Jerome R Lyn-Sue; Randy S Haluck; Ann M Rogers
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.